OM:BONEX
OM:BONEXBiotechs

Shifting CERAMENT V To FDA De Novo Review Might Change The Case For Investing In Bonesupport Holding (OM:BONEX)

BONESUPPORT has already shifted its U.S. regulatory route for CERAMENT V for bone infection from a 510(k) submission to the FDA’s De Novo pathway, extending the formal review period from 90 to 150 days while transferring substantial existing clinical and pharmacological documentation. This move suggests CERAMENT V could, if cleared, create a new product category in the U.S., echoing how CERAMENT G previously established a distinct regulatory class and potentially underscoring the uniqueness...
OM:INVE A
OM:INVE ADiversified Financial

Investor (OM:INVE A) Valuation Check After New General Counsel Joins Executive Leadership Team

Investor (OM:INVE A) has appointed Ulrika Elfving as its new General Counsel and Executive Leadership Team member, a governance focused move that could subtly shape risk management and long term value creation. See our latest analysis for Investor. The market seems to be taking this leadership change in its stride. The latest share price is SEK 318.8, and a solid 90 day share price return of 11.55 percent is backing up a strong multi year total shareholder return profile. This suggests that...
OM:CLA B
OM:CLA BFood

Cloetta (OM:CLA B) Valuation Check as CandyKing Launches First Permanent Swedish Candy Store in New York

Cloetta (OM:CLA B) just took a tangible step into the U.S. candy aisle, with subsidiary CandyKing opening a permanent Swedish Candy store in New York City, a move worth watching for long term brand building. See our latest analysis for Cloetta. That New York foothold comes on the back of strong momentum, with a roughly 13 percent 1 month share price return and a near 52 percent year to date share price gain. Long term total shareholder returns above 100 percent hint investors already see...
OM:NORION
OM:NORIONBanks

Norion Bank (OM:NORION): Valuation Check After Expanding Share Buyback to Over 5% Treasury Stake

Norion Bank (OM:NORION) just bought back another 2 million shares under its SEK 500 million repurchase program, lifting its treasury stake to over 5% and sharpening the focus on capital allocation. See our latest analysis for Norion Bank. The timing of this latest repurchase lines up with solid momentum, with a roughly 79% year to date share price return and a 73% one year total shareholder return suggesting the market is steadily rewarding Norion Bank’s story rather than chasing a short term...
OM:SKA B
OM:SKA BConstruction

Is It Too Late To Consider Skanska After Contract Wins And Strong Multi Year Share Gains

Wondering if Skanska is still good value after its run over the last few years, or if most of the upside is already priced in? This breakdown will help you decide whether to keep watching or start acting. The stock has climbed about 2.0% over the last week, 3.3% year to date and 9.3% over the past year, while its 3 year gain of 60.9% and 5 year gain of 44.6% show that investors have already been rewarded for backing the story. Recent headlines have focused on Skanska winning new...
OM:BRAV
OM:BRAVCommercial Services

Bravida (OM:BRAV) Lands SEK 25m Media Contract — Is the Stock Undervalued on Rebuilding Momentum?

Bravida Holding (OM:BRAV) just landed a nationwide framework contract with Sveriges Radio, Sveriges Television and Sveriges Radio Förvaltning, a SEK 25 million deal that quietly reinforces its role in Sweden’s critical media infrastructure. See our latest analysis for Bravida Holding. The contract news fits into a picture of quietly improving sentiment, with the latest share price at SEK 85.95 and a solid year to date share price return contrasting with weaker three year total shareholder...
OM:EMBRAC B
OM:EMBRAC BEntertainment

Does Embracer Group’s Coffee Stain Spin-Off Clarify Its Core Strategy Or Complicate It (OM:EMBRAC B)?

Embracer Group’s recent Extraordinary General Meeting approved the past distribution of its subsidiary Coffee Stain Group AB, granting shareholders one Coffee Stain share per Embracer share, with Coffee Stain’s class B shares now trading on Nasdaq First North Premier Growth Market Sweden under ticker COFFEE B. This spin-off reshapes Embracer’s portfolio by separating a key gaming asset, giving investors direct exposure to Coffee Stain while potentially clarifying the value of Embracer’s...
OM:BIOA B
OM:BIOA BBiotechs

How Leqembi’s China Insurance Listing At BioArctic (OM:BIOA B) Has Changed Its Investment Story

BioArctic’s partner Eisai has announced that Alzheimer’s drug Leqembi (lecanemab) has been added to China’s National Healthcare Security Administration “Commercial Insurance Innovative Drug List,” expanding access to early Alzheimer’s treatment in a key market following its June 2024 launch there. This move materially enhances the commercial potential of Leqembi in China, which could be important for BioArctic given its role in the drug’s development and its ongoing commercialization...
OM:VOLCAR B
OM:VOLCAR BAuto

Is Volvo Car AB (OM:VOLCAR B) Turning Embedded Data Into A Margin Story Or A Cost Sink?

In early December 2025, Volvo Cars reported that November car sales fell to 60,244 units from 66,977 a year earlier, with year-to-date volumes at 634,993 versus 689,585 in the prior period, and an Extraordinary General Meeting elected Pieter Nota and Caroline Grégoire-Sainte-Marie to the Board until the next AGM. Motorq announced a new partnership with Volvo Cars to feed embedded vehicle data into its AI platform for real-time fleet and dealership insights, highlighting Volvo’s push to turn...
OM:SKA B
OM:SKA BConstruction

How Investors Are Reacting To Skanska (OM:SKA B) Winning a US$368 Million US Data Center Deal

Skanska announced it has secured two additional contracts with a repeat client to build and complete a large data center in Virginia, USA, worth a combined US$368 million (about SEK 3.68 billion), to be booked in its US order intake for the fourth quarter of 2025. These projects deepen Skanska’s role in fast-growing digital infrastructure construction, extending its US data center workload well into 2027 and reinforcing visibility in its order backlog. We’ll now examine how this expanded US...
OM:DIOS
OM:DIOSReal Estate

Exploring 3 Undervalued Small Caps In The European Market With Insider Action

As the European market navigates a complex landscape marked by mixed performances across major indices and a slight uptick in eurozone inflation, small-cap stocks present intriguing opportunities for investors seeking growth potential amid economic fluctuations. In this environment, identifying promising small caps often involves looking at companies with solid fundamentals that can weather economic shifts and leverage insider actions as indicators of confidence.
OM:SECT B
OM:SECT BHealthcare Services

Will New NHS Cloud Wins and Pathology Deal Change Sectra's (OM:SECT B) As-a-Service Narrative?

Sectra recently secured a multi-year deal to provide its Sectra One Cloud enterprise imaging service to four NHS trusts, alongside a 7-year SEK 37.5 MSEK digital pathology contract in Sweden and a new AI-enabled reporting solution launch in the US. Together, these wins highlight how Sectra is deepening long-term, cloud-based relationships across major healthcare systems while layering in workflow and AI tools that can increase customer stickiness. We’ll now examine how expanding Sectra One...
OM:LIME
OM:LIMESoftware

European Stocks Estimated Up To 28.8% Below Intrinsic Value

As the European market navigates mixed returns with hopes of interest rate cuts from major economies, investors are keenly observing opportunities that may arise from undervalued stocks. In this context, identifying stocks trading below their intrinsic value can be a strategic move, as these equities might offer potential for growth when market conditions stabilize.
OM:RUSTA
OM:RUSTAMultiline Retail

European Undervalued Small Caps With Insider Action In December 2025

As the European markets navigate a landscape marked by mixed returns and hopes for interest rate cuts, small-cap stocks are drawing attention amid economic indicators that highlight resilience in sectors like manufacturing and housing. With the pan-European STOXX Europe 600 Index showing modest gains, investors are keenly observing opportunities within smaller companies that may be poised for growth despite broader market uncertainties. Identifying promising small caps often involves looking...
OM:SAND
OM:SANDMachinery

Is Sandvik’s Strong 2025 Share Price Run Still Supported by Fundamentals?

Wondering if Sandvik is still a smart buy after its big run, or if most of the upside is already baked in? Let us unpack what the current price really implies about its future. Sandvik shares have climbed 45.6% year to date and 39.7% over the last year, adding to a strong 67.2% three year and 75.8% five year track record. This comes even as the most recent 7 day and 30 day gains of 2.3% and 2.5% hint at a slower, more measured climb from the last close of SEK 293. Recent moves have been...